A national strategic change in treatment policy for rectal cancer implementation of total mesorectal excision as routine treatment in Norway. A national audit

被引:438
作者
Wibe, A [1 ]
Moller, B
Norstein, J
Carlsen, E
Wiig, JN
Heald, RJ
Langmark, F
Myrvold, HE
Soreide, O
机构
[1] Univ Trondheim Hosp, Dept Surg, N-7006 Trondheim, Norway
[2] Canc Registry Norway, Oslo, Norway
[3] Univ Oslo, Ullevaal Hosp, N-0407 Oslo, Norway
[4] Norwegian Radium Hosp, Oslo, Norway
[5] N Hampshire Hosp, Basingstoke, Hants, England
[6] Univ Oslo, Natl Hosp, Oslo, Norway
关键词
total mesorectal excision; rectal cancer; local recurrence; anastomotic; dehiscence; survival;
D O I
10.1007/s10350-004-6317-7
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
INTRODUCTION: Rectal cancer surgery has been characterized by a high incidence of local recurrence, an occurrence which influences survival negatively. In Norway there was a growing recognition that local recurrence rates were related to surgeon performance and that surgeons applying a standardized surgical technique in the form of total mesorectal excision could achieve better results. This contrasts with the prevailing argument voiced by many opinion leaders that local recurrence rates and possibly survival rates can only be improved by adjuvant or neoadjuvant treatment strategies. The Norwegian Rectal Cancer Project initiated in 1993-aimed at improving the outcome of patients with rectal cancer by implementing total mesorectal excision as the standard rectal resection technique. METHODS: This observational national cohort study covers all new patients (3,319) with rectal cancer from a population of 4.5 million treated between November 1993 and August 1997. The main outcome measures were local recurrence, survival, and postoperative mortality and morbidity rates. The technique of total mesorectal excision was compared with conventional surgery. RESULTS: The proportion of patients undergoing total mesorectal excision was 78 percent in 1994, increasing to 92 percent in 1997. The observed local recurrence rate for patients undergoing a curative resection was 6 percent in the group treated by total mesorectal excision and 12 percent in the conventional surgery group. Four-year survival rate was 73 percent after total mesorectal excision and 60 percent after conventional surgery. Postoperative mortality rate was 3 percent and the anastomotic dehiscence rate was 10 percent. Radiotherapy was given to 5 percent and chemotherapy to 3 percent of the patients in the curative resection group. CONCLUSION: A refinement of the surgical resection technique for rectal cancer can be achieved on a national level, the technique of total mesorectal excision can be widely distributed, and surgery alone can give good results.
引用
收藏
页码:857 / 866
页数:10
相关论文
共 26 条
[1]   LOCAL RECURRENCE OF COLORECTAL-CANCER - THE PROBLEM, MECHANISMS, MANAGEMENT AND ADJUVANT THERAPY [J].
ABULAFI, AM ;
WILLIAMS, NS .
BRITISH JOURNAL OF SURGERY, 1994, 81 (01) :7-19
[2]  
Bjerkeset T, 1996, EUR J SURG, V162, P643
[3]   RESULTS OF EXTENDED SURGERY FOR CANCER OF THE RECTUM AND SIGMOID [J].
BONFANTI, G ;
BOZZETTI, F ;
DOCI, R ;
BATICCI, F ;
MAROLDA, R ;
BIGNAMI, P ;
GENNARI, L .
BRITISH JOURNAL OF SURGERY, 1982, 69 (06) :305-307
[4]  
COHEN AM, 1995, CANC OLON RECTUM ANU
[5]  
Dahlberg M, 1998, BRIT J SURG, V85, P515
[6]   THE EFFECT OF MALIGNANT AND INFLAMMATORY FIXATION OF RECTAL-CARCINOMA ON PROGNOSIS AFTER RECTAL EXCISION [J].
DURDEY, P ;
WILLIAMS, NS .
BRITISH JOURNAL OF SURGERY, 1984, 71 (10) :787-790
[7]   THE ROGERS,WILL PHENOMENON - STAGE MIGRATION AND NEW DIAGNOSTIC-TECHNIQUES AS A SOURCE OF MISLEADING STATISTICS FOR SURVIVAL IN CANCER [J].
FEINSTEIN, AR ;
SOSIN, DM ;
WELLS, CK .
NEW ENGLAND JOURNAL OF MEDICINE, 1985, 312 (25) :1604-1608
[8]   CLINICOPATHOLOGICAL STAGING FOR COLORECTAL-CANCER - AN INTERNATIONAL DOCUMENTATION SYSTEM (IDS) AND AN INTERNATIONAL COMPREHENSIVE ANATOMICAL TERMINOLOGY (ICAT) [J].
FIELDING, LP ;
ARSENAULT, PA ;
CHAPUIS, PH ;
DENT, O ;
GATHRIGHT, B ;
HARDCASTLE, JD ;
HERMANEK, P ;
JASS, JR ;
NEWLAND, RC .
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 1991, 6 (04) :325-344
[9]  
Havenga K, 1997, RECTAL CANC SURG OPT, P134
[10]  
Heald RJ, 1998, SEMIN SURG ONCOL, V15, P66, DOI 10.1002/(SICI)1098-2388(199809)15:2<66::AID-SSU2>3.0.CO